Table 2.

Pretreatment phenotypic and molecular characteristics of patients

Patient no.CD25CD123CD103CD11cCD20 sites/cellIGHV%homologyBRAFAnnexin A1
RG01+++256,0006–187.65%Wild-type
RG02++98,000Not doneNot doneWild-type
RG03+++195,0003–994.45%Wild-type
RG04+++124,0004–3499.58%Wild-type
RG05+++127,0004–34100%Wild-type
RG06+++133,0004–34100%Wild-type
RG07+++185,0003–30100%Wild-type
RG08+++192,0001–6999.17%Wild-type
RG09++189,0004–499.17%Wild-type
RG10+++227,0001–4697.13%Wild-type